Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Credit agrmnt [a]
CareMax, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Investor presentation, Quarterly results
Docs: "CareMax Reports Second Quarter 2023 Results • Second Quarter Medicare Advantage Membership of 102,500, up 177% year-over-year • Second Quarter Total Revenue of $224.4 million, up 30% year-over-year • Raising Full Year 2023 Revenue Guidance; Reaffirming Full Year 2023 Adjusted EBITDA Guidance Miami, FL - August 9, 2023 - CareMax, Inc. , a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2023. “We continued to deliver on our growth strategy, ending the quarter with 102,500 Medicare Advantage members, up 177% year-over-year, and have confidence in achieving both our near and long-term membership targets that we announced at our investor day in March. Our second quarter performance w...",
"Second Quarter 2023 Earnings Presentation August 9, 2023 EX-99.2"
06/12/2023 4 Flynn James E (10% Owner) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 options to buy @ $0
06/12/2023 4 Berg Kevin (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 options to buy @ $0
06/12/2023 4 Wirges Kevin (EVP, Treasurer and CFO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 4,433 restricted stock units @ $0
Granted 33,250 rights @ $0
Granted 66,500 restricted stock units @ $0
Granted 66,500 options to buy @ $3.72, valued at $247.4k
06/12/2023 4 Shulkin David (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 38,750 restricted stock units @ $0
06/12/2023 4 Rodriguez Jose Ramon (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 48,750 restricted stock units @ $0
06/12/2023 4 OQuinn Ryan (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 restricted stock units @ $0
06/12/2023 4 de Solo Carlos A. (President and CEO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 14,300 restricted stock units @ $0
Granted 107,250 rights @ $0
Granted 214,500 restricted stock units @ $0
Granted 214,500 options to buy @ $3.72, valued at $797.9k
06/12/2023 4 de Solo Alberto (EVP and COO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 6,300 restricted stock units @ $0
Granted 47,250 rights @ $0
Granted 94,500 restricted stock units @ $0
Granted 94,500 options to buy @ $3.72, valued at $351.5k
06/12/2023 4 de la Torre Ralph (10% Owner) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 restricted stock units @ $0
06/12/2023 4 Cho Bryan (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 38,750 restricted stock units @ $0
06/12/2023 4 Assapimonwait Beatriz Maria (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 restricted stock units @ $0
06/12/2023 4 Omachonu Vincent (Director) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 restricted stock units @ $0
05/16/2023 4 Wirges Kevin (EVP, Treasurer and CFO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 10,632 restricted stock units @ $0
05/16/2023 4 Shulkin David (Director) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 18,585 restricted stock units @ $0
05/16/2023 4 Rodriguez Jose Ramon (Director) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 23,381 restricted stock units @ $0
05/16/2023 4 de Solo Carlos A. (President and CEO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 34,293 restricted stock units @ $0
05/16/2023 4 de Solo Alberto (EVP and COO) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 15,108 restricted stock units @ $0
05/16/2023 4 Cho Bryan (Director) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 16,187 restricted stock units @ $0
05/16/2023 4 Assapimonwait Beatriz Maria (Director) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 16,187 restricted stock units @ $0
05/16/2023 4 Omachonu Vincent (Director) has filed a Form 4 on CareMax, Inc.
Txns: Exercised 16,187 restricted stock units @ $0
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Investor presentation, Quarterly results
Docs: "CAREMAX, INC. CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2023 December 31, 2022 ASSETS Current Assets Cash and cash equivalents $ 44,222 $ 41,626 Accounts receivable, net 158,989 151,036 Risk settlement assets 858 707 Other current assets 5,928 3,968 Total Current Assets 209,998 197,336 Property and equipment, net 22,726 21,006 Operating lease right-of-use assets 115,018 108,937 Goodwill, net 602,643 700,643 Intangible assets, net 118,189 123,585 Deferred debt issuance costs 1,842 1,685 Other assets 27,286 17,550 Total Assets $ 1,097,701 $ 1,170,743 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable $ 8,134 $ 7,687 Accrued expenses 18,602 18,631 Risk settlement liabilities 13,868 14,171 Related party debt, net 31,548 30,277 Current portion of third-party debt, ...",
"5 6 7 1 2 3"
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/29/2023 10-Q/A Quarterly Report for the period ended September 30, 2022 [amend]
03/29/2023 10-Q/A Quarterly Report for the period ended June 30, 2022 [amend]
03/29/2023 10-Q/A Quarterly Report for the period ended March 31, 2022 [amend]
03/29/2023 10-K/A Annual Report for the period ended December 31, 2021 [amend]
03/29/2023 10-Q/A Quarterly Report for the period ended September 30, 2021 [amend]
03/15/2023 4 Cho Bryan (Director) has filed a Form 4 on CareMax, Inc.
Txns: Bought 10,000 shares @ $3.46, valued at $34.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy